Avoro Ventures, based in New York, backs life sciences companies at Series B, can lead rounds with checks over $30 million, and its latest fund is $186 million.
4 people on the investing team, 3 of them partners who can make the call. Partners are listed first.



Work here and something is wrong? Ask for a correction.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Avoro Ventures reports entry at series b.
Avoro Ventures reports checks of $30M and up.
Yes. Avoro Ventures says it can lead.
Behzad Aghazadeh (Managing Partner), Mark Chin (Investment Partner), Uya Chuluunbaatar (Investment Partner).
No recent activity since September 2026.
Work at Avoro Ventures? Claim or correct this profile.